Dutch Minister plans to implement new reimbursement system for high-cost medicine [Advocacy Lab Content]
Dutch raise concerns about the relative effectiveness of an increasing number of new medicines at the time of their market authorisation, a spokesperson for outgoing Dutch Medical Care Minister Pia Dijkstra told Euractiv.